Levi & Korsinsky Investigates Mereo BioPharma Group plc (MREO) Over Potential Securities Fraud Allegations

NEW YORK, NY / ACCESS Newswire / January 3, 2026 / Levi & Korsinsky notifies investors that it has commenced an investigation into Mereo BioPharma Group plc ("Mereo BioPharma Group plc") (NASDAQ:MREO) concerning potential violations of the federal securities laws. On December 29, 2025, before the market opened, Mereo announced results from its Phase 3 […]

ATTENTION RARE Shareholders: Lost Money on Ultragenyx Pharmaceutical Inc.? Contact Levi & Korsinsky About Investigation

NEW YORK, NY / ACCESS Newswire / January 3, 2026 / Levi & Korsinsky notifies investors that it has commenced an investigation into Ultragenyx Pharmaceutical Inc. ("Ultragenyx Pharmaceutical Inc.") (NASDAQ:RARE) concerning potential violations of the federal securities laws. What Happened? • On December 29, 2025, Ultragenyx announced the results from both its Phase III Orbit

Fraud Investigation: Levi & Korsinsky Investigates Corcept Therapeutics Incorporated (CORT) on Behalf of Shareholders

NEW YORK, NY / ACCESS Newswire / January 3, 2026 / Levi & Korsinsky notifies investors that it has commenced an investigation into Corcept Therapeutics Incorporated ("Corcept Therapeutics Incorporated") (NASDAQ:CORT) concerning potential violations of the federal securities laws. What Happened? • On December 31, 2025, Corcept announced it received a CRL from the FDA, denying

Levi & Korsinsky Urges Telix Pharmaceuticals Ltd. (TLX) Shareholders to Act Before Lead Plaintiff Deadline January 9, 2026

NEW YORK, NY / ACCESS Newswire / January 3, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Telix Pharmaceuticals Ltd. (NASDAQ:TLX) securities. If you suffered a loss on your Telix Pharmaceuticals Ltd. investment and would like to explore

Scroll to Top